Friday, April 3, 2026
30.4 C
Bengaluru

Doctors Still Considered Noble

Screen Shot 2016-07-03 at 5.35.50 am

[wpfilebase tag=file id=78 tpl=download-button /]

Inside this Issue

1. Five Disruptive Forces that are Shaking Up Pharma! by Piyush Agarwal
A curtain raiser on a few disruptions that will permanently alter the pharma marketing landscape in the near future.

2. The Dangers of Labelling Your Sales Team Members and Having a Closed Mindset by K. Hariram
It is easy to label your sales team members as inept but it closes the doors to improvement and progress.

3. 5 Leadership Lessons for Frontline Managers: Building an E2 Team by Vivek Hattangadi
How the pharma frontline manager can develop a high-performance team by fostering Empathy and Excellence in the team.

4. How to Hire a Future-Ready Field Force by Anjali Sharma and Chandan Kumar
As the pharma industry undergoes rapid change, the job roles and job descriptions of the sales force will also change. Hiring Managers need to keep this in mind.

5. Handling Sales Rejections Professionally by RB Balakrishna
How to handle sales rejections as a business problem to be solved rather than a personal affront.

6. Deciding on a Business Expansion Strategy by Weighing the Risks and Gains by Pankaj Mehrotra
An introduction to the use of the Ansoff Matrix to weigh the risks and the benefits of pursuing a particular growth strategy.

Hot this week

Hype and Happening: GLP-1 Growth Story – Follow the Patient, not the Primary Sales

Is Obesity (Drugs) Masking Underlying (Metabolic) Risk Factors in...

Trump’s 100% Drug Tariffs Explained: The Surprising Opportunity for India

How the 2026 U.S. tariff action on branded drugs...

Can Eli Lilly Outrun the Same-Glutide Stampede with Tirzepatide and Orforglipron?

The "aspirinization" of obesity—moving from a niche, high-cost injectable...

IPM February 2026: Market Intelligence Report

Executive Summary The Indian Pharmaceutical Market (IPM) sustained its growth...

FieldForce Is Not Your Frontline Anymore. Meet the New Force in Healthcare

When drones first appeared on battlefields, military establishments reacted...

Topics

Hype and Happening: GLP-1 Growth Story – Follow the Patient, not the Primary Sales

Is Obesity (Drugs) Masking Underlying (Metabolic) Risk Factors in...

Can Eli Lilly Outrun the Same-Glutide Stampede with Tirzepatide and Orforglipron?

The "aspirinization" of obesity—moving from a niche, high-cost injectable...

IPM February 2026: Market Intelligence Report

Executive Summary The Indian Pharmaceutical Market (IPM) sustained its growth...

FieldForce Is Not Your Frontline Anymore. Meet the New Force in Healthcare

When drones first appeared on battlefields, military establishments reacted...

Razumab at 11: A Decade of Disruption, Safety Lessons, and the New Biosimilar Reality

Abstract When Intas Pharmaceuticals launched Razumab in June 2015 as...

Semaglutide: Just Another Off-Patent Generic? Or a Different Beast Entirely?

As over 50 generic versions of the blockbuster weight-loss...
spot_img

Related Articles

spot_imgspot_img